share_log

Wells Fargo Upgrades Monte Rosa Therapeutics to Overweight, Announces $19 Price Target

Benzinga Real-time News ·  Jan 3, 2023 04:37

Wells Fargo analyst Derek Archila upgrades Monte Rosa Therapeutics (NASDAQ:GLUE) from Equal-Weight to Overweight and announces $19 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment